Business Wire

MN-INTELLIGENT-NUTRIENTS

Del
The Beauty Industry Loses an Icon; Horst Rechelbacher, Founder of Aveda & Intelligent Nutrients, Dies at Age 72

Horst M. Rechelbacher died peacefully at his home in Osceola, Wisconsin, Saturday, February 15, 2014 after his battle with pancreatic cancer. He was 72 years old.

Rechelbacher was a pioneer in the now-mainstream sustainable health and beauty industry. He founded Aveda Corporation in 1978 with a vision for plant-based products. He grew the company into a powerhouse, and led the movement towards the use of organic ingredients, fair-trade sourcing, aromatherapy and recycled packaging along with numerous other innovations.

He was an outspoken critic of the environmental and personal dangers of petrochemicals, synthetic ingredients, conventional pesticide-based farming and chemical-laden manufacturing methods. He viewed his products as a way to create awareness as well as provide healthier, safer alternatives.

Born in Klagenfurt, Austria, on November 11, 1941, he began apprenticing as a hairdresser at 14. He came to the US, and specifically Minneapolis, Minnesota, in 1964. After being injured in a car accident, he remained in Minnesota to take care of his medical expenses and opened his first Horst & Friends Salon in 1965. He first introduced his line of shampoos in 1977, the first plant-based beauty line, which became Aveda. He was a visionary, entrepreneur and leader who played by his own rules. This led to an innovative company culture, whose work spawned a revolution in the beauty business and influenced many other industries as well. His legacy includes the Aveda Concept Salons and the Aveda Institute and ushering in a new consciousness in the beauty and wellness industry.

A man of his time and ahead of it, his search into the world of greater traditional wisdom and plant study began in the mid-60s. He often credited his mother, an herbalist, for this lifelong interest. His never-ending study of plant-based medicine and health took him from India ashrams to primitive tribes to partnerships with the Henry Ford West Bloomfield Hospital, the Children’s Hospital of MN and the Mayo Clinic. He collaborated with noted physicians, chemists and pharmacologists, as well rock stars, traditional healers and shaman worldwide.

Rechelbacher sold Aveda Corporation to The Estee Lauder Companies in 1997 that was then the largest sale of its kind. His focus then shifted to Intelligent Nutrients, where he continued to pioneer in the beauty industry – this time focusing on certified organic products using food-grade ingredients and plant stem-cell science, and continuing his life-long vision of creating safer, healthier products for consumers and the planet. In 2012, he turned the co-presidency of the company to his longtime partner Kiran Stordalen and daughter Nicole Thomas. Under their leadership the company will continue to advance his life’s work and mission.

Rechelbacher was recognized as one of the most notable Austrians living in America by the Austrian press, along with Arnold Schwarzenegger and Wolfgang Puck . Vanity Fair magazine honored him as one of the most influential environmentalists in the U.S. in 1995 and again in 2005. He is one of the three original founders of Business for Social Responsibility, which focused its mission on business and the sustainability of all living species. In 2004, he became a founding member of the Organic Center, a non-profit dedicated to organic education, research and promotion. NAHA (North American Hairdressers Association) honored him with the Lifetime Achievement Award, and in 2007, the International Congress of Esthetics and Spa presented Horst with the Crystal Award. Rechelbacher also received the Rachel Carson Award for a Lifetime Commitment to Environmental Ethics & Integrity. Also in 2007, the Spa & Salon Professional Association honored him as an Industry Innovator and Legend for his lifetime contribution to the cosmetology industry. The Twin Cities Business Magazine inducted Horst into their 2008 Minnesota Business Hall of Fame, acknowledging his contributions and recognizing him as one of the states’ most accomplished business leaders of all time. In 2009, the President of Austria awarded Horst the "Decoration of Honour in Gold for Services to the Republic of Austria ."

Horst, a self-proclaimed “student” of nature, never lost his fascination for learning. He signed all his correspondence “Yours in service for a green, healthy and non-violent planet,” and left this planet with the same mission. There will never be another like him.

No. No. No.

Contact:

Press Contact:
For Intelligent Nutrients:
Chris Molinari, 201-970-6665
chris.molinari@gmail.com

Link:

Multimedia Gallery

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

A-CAP Announces Successful Divestiture of Standard de Liège SA and Immobilière du Standard de Liège SRL6.6.2025 22:32:00 CEST | Press release

Successful Transaction Marks Another Milestone in A-CAP’s Soccer Club Portfolio Strategy Advantage Capital Holdings, LLC (“A-CAP” or “The Company”), a New York-based insurance and financial services company with over $12 billion in assets, today announced the successful divestiture of Standard de Liège SA (“Standard Liège” or the “Club”), one of Belgium's most historic soccer clubs, and Immobilière du Standard de Liège SRL, the corporate entity that owns the Club's stadium, Maurice Dufrasne Stadium, to a consortium of buyers led by Standard Liège Chief Executive Officer Giacomo Angelini. This transaction marks the end of 777 Partners’ legacy involvement with the Club and sets the stage for the Club’s future growth and success, both on and off the field. Benefits of the transaction include: Increased stability across the Club’s shareholder base, which clears the path for future investments, Operational clarity, establishing a unified direction that will allow both players and management

Populous Acquires Fentress Architects, Expanding Global Aviation Portfolio6.6.2025 20:00:00 CEST | Press release

Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/ Los Angeles International Airport. Designed by Fentress Architects. This strategic acquisition unites two of the most respected names in architecture, combining Populous’ unparalleled expertise in designing memorable experiences with Fentress’ award-winning portfolio of aviation, civic and cultural landmarks. The acquisition significantly broadens the scope and scale of services that Populous can offer clients across the globe. Bruce Miller, Populous Global Chair and CEO, commented: “We are committed to expanding the breadth of our practice. Fentress Architects has lon

Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 18:00:00 CEST | Press release

- Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with cystic fibrosis - - Oral presentation on new post hoc data from randomized, controlled and open-label trials suggest improved quality of life results with ALYFTREK compared to TRIKAFTA® – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conferenc

Andersen Consulting tilføjer dimension med David and Golyat6.6.2025 16:33:00 CEST | Pressemeddelelse

Andersen Consulting udbygger sin globale konsulentkapacitet gennem en samarbejdsaftale med David and Golyat, en filippinsk konsulentvirksomhed inden for digital strategi. Med et stærkt fokus på business intelligence, kundeindsigt og digital first-eksekvering arbejder David and Golyat med kunder på tværs af flere sektorer – herunder regeringer, udviklingsorganisationer og private virksomheder – for at skabe langsigtet værdi gennem datainformerede beslutninger. Miko David, administrerende partner i David and Golyat, siger: "Vi ser frem til samarbejdet med Andersen Consulting, da det er en milepæl i vores vækstforløb. Ved at kombinere vores ekspertise inden for digital strategi og Andersen Consultings globale platform er vi i stand til at levere endnu større værdi til kunder, der navigerer på komplekse markeder." "Dette samarbejde betyder, at vi kan tilføre en ekstra dimension til vores globale konsulentplatform," siger Mark L. Vorsatz, global bestyrelsesformand og administrerende direktø

IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10th Anniversary Year of NAHYCO® Technology6.6.2025 16:00:00 CEST | Press release

IBSA Derma, the dermoaesthetic division of Swiss company IBSA, will participate in the 18th IMCAS Asia Congress in Bangkok, gathering over 3,000 professionals from across the region to explore the future of aesthetic and regenerative medicine.With the presence in the Congress and a dedicated scientific symposium, the company reaffirms its commitment to advancing bioremodeling approaches and promoting a holistic, science-driven vision of authentic beauty.This year marks a key milestone for IBSA Derma: 10 years of NAHYCO® Technology, a patented innovation in hyaluronic acid science that continues to shape the future of tissue regeneration. IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye